Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #173309 on Anavex Life Sciences Corp (AVXL)
XenaLives
11/29/18 1:55 PM
#173313 RE: Investor2014 #173309
Primary Outcome Measures : Incidence of Adverse Events [ Time Frame: 7 weeks ] Incidence of Adverse Events Maximum Plasma Concentration [Cmax] of ANAVEX2-73 [ Time Frame: 7 weeks ] PK of ANAVEX2-73 and metabolite Area Under the Curve [AUC] of ANAVEX2-73 [ Time Frame: 7 weeks ] PK of ANAVEX2-73 and metabolite Lipid panel [ Time Frame: 7 weeks ] Significant laboratory findings
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads